Diazoxide

e5 Pharma

Oral liq 50 mg per mlNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

TensurilBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.Same form
ProglycemCanada · 100 MG · Capsule · Merck Canada INCSame substance
Hyperstat Inj 15MG/MLCanada · 15 MG / ML · Liquid · Schering-Plough Canada INCSame substance
Proglycem Susp 50MG/MLCanada · 50 MG / ML · Suspension · Schering-Plough Canada INCSame substance
ProglicemItaly · Capsula rigida · MSD Italia S.R.L.Same substance
Proglicem, capsules 100 mgNetherlands · Capsule, hard · Merck Sharp & Dohme B.V.Same substance
DiazoxideUnited States · 50MG/ML · suspension · E5 Pharma INCSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Diazoxide

e5 Pharma

Oral liq 50 mg per mlNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ProglycemUnited States · 50MG/ML · suspension · Teva Branded Pharm

DiazoxideUnited States · 15MG/ML · injectable · Abraxis Pharm

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Diazoxide
Dosage form: Oral liq 50 mg per ml
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)

PHARMAC

ProglicemDiazoxide · Cap 100 mgNew Zealand

ProglycemDiazoxide · Oral liq 50 mg per mlNew Zealand